# Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease

> **NCT04139122** · PHASE1,PHASE2 · COMPLETED · sponsor: **Senju Pharmaceutical Co., Ltd.** · enrollment: 89 (actual)

## Conditions studied

- Dry Eye Disease
- Dry Eye Syndrome

## Interventions

- **DRUG:** SJP-0132
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04139122
- **Lead sponsor:** Senju Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-05
- **Primary completion:** 2020-03-03
- **Final completion:** 2020-03-03
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2023-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04139122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04139122, "Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04139122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*